Praj Industries Ltd: From Ethanol Dreams to Profit Hangovers – 400 Patents, But 91% Profit Drop 🍻➡️💸

1. At a Glance

Praj Industries is India’s ethanol poster boy — 71% of revenues come from BioEnergy, it flaunts 400+ patents, and even bagged the title of “No.1 Hottest Company in Global Bioeconomy” in Washington DC. Yet, Q1 FY26 net profit was just ₹5.3 Cr — a 91% YoY drop. Basically, Praj is like that friend who talks big about “clean energy disruption” but can’t even pay the bar bill.

2. Introduction

Founded in 1983, Praj began as a small engineering firm but morphed into India’s most famous ethanol and biofuel story. Today, it has 1000+ references across 100 countries, builds both 1G & 2G ethanol plants, commercial-scale CBG units, brewery equipment, and even hi-purity pharma water systems.

Sounds impressive, right? But look closer. FY24 order book was ₹3,855 Cr (76% Bioenergy). Yet revenues in FY25 fell to ₹3,169 Cr, and profits crashed to ₹140 Cr. That’s the corporate equivalent of filling a whisky bottle with soda water — plenty of volume, no kick.

And while Praj is riding the global ethanol wave (Brazil, Africa, USA contracts), tariffs, liquidity issues, and execution delays have hit margins. Investors are left wondering: is Praj a genuine clean-tech innovator, or just a fancy sugarcane juicer with a PR team?

3. Business Model – WTF Do They Even Do?

Praj’s pitch deck could impress even Elon Musk, but here’s the simplified truth:

• BioEnergy (71% revenue): 1G (grain/sugar to ethanol), 2G (waste-to-ethanol), CBG plants, SAF (sustainable aviation fuel), marine biofuels, biohydrogen. Basically, if it ferments, they’ll sell it.
• HiPurity Systems (8%): Sterile water & modular systems for pharma/nutraceuticals. Subsidiary is a quiet money-spinner.
• Engineering (21%): Wastewater plants, breweries, and heavy-duty process equipment for oil & gas.
• Global Presence: 5 Indian plants + offices in USA, Thailand, Philippines. 20% exports, 80% domestic.

The hook? Praj isn’t just an EPC contractor. It patents its tech, licenses it globally, and now wants to lead in SAF and biohydrogen — markets where even big oil companies are still scratching their heads.

4. Financials Overview

Commentary: From ₹84 Cr profit to ₹5 Cr in a year? Even Bollywood sequels don’t flop this badly.

5. Valuation – Fair Value Range Only

• P/E Method: EPS FY25 = ₹7.62. Industry P/E =